Join
Live feed
·
INSIDERFilingvia Quantisnow
Supernus Pharmaceuticals Inc. logo

Director Gemayel Georges sold $1,002,811 worth of shares (18,787 units at $53.38) and exercised 7,905 shares at a strike of $25.30, decreasing direct ownership by 29% to 27,277 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SUPN (Supernus Pharmaceuticals Inc.) and more on Quantisnow.

Director Gemayel Georges sold $1,002,811 worth of shares (18,787 units at $53.38) and exercised 7,905 shares at a strike of $25.30, decreasing direct ownership by 29% to 27,277 units (SEC Form 4) | Quantisnow